(Q47569147)

English

Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

9

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

author name string

Yaning Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

A Venkatesh Bhattaram

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

Pravin R Jadhav

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

Lawrence J Lesko

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

Rajanikanth Madabushi

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

J Robert Powell

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

Wei Qiu

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

He Sun

8

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

Jenny J Zheng

10

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

Jogarao V S Gobburu

11

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

publication date

1 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

48

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

146-156

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applications

1 reference

https://api.crossref.org/works/10.1177%2F0091270007311111

21 January 2018

Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006.

1 reference

https://api.crossref.org/works/10.1177%2F0091270007311111

21 January 2018

Paving the critical path: how can clinical pharmacology help achieve the vision?

1 reference

https://api.crossref.org/works/10.1177%2F0091270007311111

21 January 2018

Medication compliance as a feature in drug development

1 reference

https://api.crossref.org/works/10.1177%2F0091270007311111

21 January 2018

Comparison of four basic models of indirect pharmacodynamic responses

1 reference

https://api.crossref.org/works/10.1177%2F0091270007311111

21 January 2018

The price of innovation: new estimates of drug development costs

1 reference

https://api.crossref.org/works/10.1177%2F0091270007311111

21 January 2018

Model-based drug development: the road to quantitative pharmacology

1 reference

https://api.crossref.org/works/10.1177%2F0091270007311111

21 January 2018

Impact of population pharmacokinetic-pharmacodynamic analyses on the drug development process: experience at Parke-Davis

1 reference

https://api.crossref.org/works/10.1177%2F0091270007311111

21 January 2018

Model-based drug development

1 reference

https://api.crossref.org/works/10.1177%2F0091270007311111

21 January 2018

How modeling and simulation have enhanced decision making in new drug development

1 reference

https://api.crossref.org/works/10.1177%2F0091270007311111

21 January 2018

Pharmacometrics at FDA: evolution and impact on decisions

1 reference

https://api.crossref.org/works/10.1177%2F0091270007311111

21 January 2018

Identifiers

10.1177/0091270007311111

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/18199891

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47569147&oldid=908707603"